Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 11/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 1.00 |
| ▸ | MEN1 | O00255 | 9/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 9/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | LOX | P28300 | 1/20 | 0.42 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.42 |
| ▸ | LOXL4 | Q96JB6 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Barbituric Acid SCHEMBL11227752 | 0.88 | MAPT (0.77) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL5928770 | 0.80 | MAPT (0.67) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL9467010 | 0.73 | MAPT (0.57) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL31579474 | 0.72 | MAPT (1.00) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL31579529 | 0.72 | MAPT (1.00) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL6733051 | 0.71 | MEN1 (0.64) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL9511915 | 0.71 | MAPT (0.55) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL28700332 | 0.71 | MAPT (0.58) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL4664731 | 0.70 | MAPT (0.70) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL23878375 | 0.69 | MAPT (0.51) | MAPTALDH1A1MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0378373-B1 | Photohardenable compositions and their use in producing images | MEAD CORP (US) | 1997-03-05 | — | — | EP | claimed |
| US-5079126-A | Pyrazoline-5-one compound, reduction of reciprocity failure, imaging method, microcapsules coated on support | THE MEAD CORPORATION (US) | 1992-01-07 | — | — | US | claimed |
| CN-1046331-A | The photohardenable composition that contains five member aromatic group with imine moiety | MEAD CORP (US) | 1990-10-24 | — | — | CN | claimed |
| EP-0378373-A2 | Photohardenable compositions and their use in producing images | THE MEAD CORPORATION (US) | 1990-07-18 | — | — | EP | claimed |
| US-4822891-A | ANALYZING HYDROGEN PEROXIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1989-04-18 | — | — | US | claimed |
| US-4711963-A | 4-amino-2-methyl-3-phenyl-1-(2,4,6-trichlorophenyl)-3-pyrazolin-5-one | FUJI PHOTO FILM CO., LTD. (JP) | 1987-12-08 | — | — | US | claimed |
| US-4353912-A | NEUROLEPTIC AGENTS | NORTHEASTERN UNIVERSITY (US) | 1982-10-12 | — | — | US | claimed |
| US-4028183-A | MULTISTAGE, MULTIZONAL; ATP-METHIONINE-ADENOSYL-TRANSFERASE ON ATP | BIORESEARCH LIMITED (IT) | 1977-06-07 | — | — | US | claimed |
| US-3954726-A | Double salts of S-adenosil-L-methionine | BIORESEARCH LIMITED (IT) | 1976-05-04 | — | — | US | claimed |
| JP-2192466-A | — | — | None | — | — | JP | disclosed |
| US-12577344-B2 | One component (1K) composition based on epoxy resin | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2026-01-15 | — | — | US | disclosed |
| US-12458049-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2025-11-04 | — | — | US | disclosed |
| EP-3916033-B1 | ONE COMPONENT (1K) COMPOSITION BASED ON EPOXY RESIN | HENKEL AG & CO KGAA (DE) | 2025-10-29 | — | — | EP | disclosed |
| US-3963748-A | 1-Phenyl-3-azacarbocyclic-ureas | STERLING DRUG INC. (US) | 1976-06-15 | — | — | US | disclosed |
| US-3960886-A | Substituted N-arylanilines | STERLING DRUG INC. (US) | 1976-06-01 | — | — | US | disclosed |
| US-3959309-A | ANALGESICS, PSYCHOTROPIC, ANTIHISTAMINE | STERLING DRUG INC. (US) | 1976-05-25 | — | — | US | disclosed |
| US-3954726-A | Double salts of S-adenosil-L-methionine | BIORESEARCH LIMITED (IT) | 1976-05-04 | — | — | US | disclosed |
| US-3947395-A | Epoxy surface coating compositions | HITACHI, LTD. (JA) | 1976-03-30 | — | — | US | disclosed |
| US-3940421-A | Intermediates for the preparation of thienobenzopyrans and thiopyranobenzopyrans | ARTHUR D. LITTLE, INC. (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458049-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | MAPT 3044/4885ALDH1A1 2625/4885MEN1 679/4885 |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | TAS2R7, TAS2R31, TAS2R40 | MAPT 1667/4885ALDH1A1 3539/4885MEN1 1131/4885 |
| US-12577344-B2 | One component (1K) composition based on epoxy resin | CBR1, AGTR1, SMARCC1 | MAPT 4584/4885ALDH1A1 225/4885MEN1 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.